Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
1.
Vaccine ; 39(2): 255-262, 2021 01 08.
Article in English | MEDLINE | ID: mdl-33317870

ABSTRACT

BACKGROUND: Pandemic planning has historically been oriented to respond to an influenza virus, with vaccination strategy being a key focus. As the current COVID-19 pandemic plays out, the Australian government is closely monitoring progress towards development of SARS-CoV2 vaccines as a definitive intervention. However, as in any pandemic, initial supply will likely be exceeded by demand due to limited manufacturing output. METHODS: We convened community juries in three Australian locations in 2019 to assess public acceptability and perceived legitimacy of influenza pandemic vaccination distribution strategies. Preparatory work included literature reviews on pandemic vaccine allocation strategies and on vaccine allocation ethics, and simulation modelling studies. We assumed vaccine would be provided to predefined priority groups. Jurors were then asked to recommend one of two strategies for distributing remaining early doses of vaccine: directly vaccinate people at higher risk of adverse outcomes from influenza; or indirectly protect the general population by vaccinating primary school students, who are most likely to spread infection. RESULTS: Thirty-four participants of diverse backgrounds and ages were recruited through random digit dialling and topic-blinded social media advertising. Juries heard evidence and arguments supporting different vaccine distribution strategies, and questioned expert presenters. All three community juries supported prioritising school children for influenza vaccination (aiming for indirect protection), one by 10-2 majority and two by consensus. Justifications included that indirect protection benefits more people and is likely to be more publicly acceptable. CONCLUSIONS: In the context of an influenza pandemic, informed citizens were not opposed to prioritising groups at higher risks of adverse outcomes, but if resources and epidemiological conditions allow, achieving population benefits should be a strategic priority. These insights may inform future SARS-CoV-2 vaccination strategies.


Subject(s)
COVID-19/epidemiology , Health Care Rationing/organization & administration , Immunization Programs/organization & administration , Influenza Vaccines/supply & distribution , Influenza, Human/prevention & control , Pandemics/prevention & control , Vaccination/ethics , Adolescent , Adult , Australia/epidemiology , Child , Female , Humans , Immunization Schedule , Influenza Vaccines/administration & dosage , Influenza Vaccines/economics , Influenza, Human/epidemiology , Influenza, Human/immunology , Influenza, Human/virology , Male , Middle Aged , Orthomyxoviridae/immunology , Public Health/economics , Public Health/methods , SARS-CoV-2/pathogenicity , Vaccination/economics , Vaccination Coverage/statistics & numerical data
2.
Public Health ; 129(8): 1021-9, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25917003

ABSTRACT

OBJECTIVES: 'Nanny-state' accusations can function as powerful rhetorical weapons against interventions intended to promote public health. Public health advocates often lack effective rebuttals to these criticisms. Nanny-state accusations are largely accusations of paternalism. They conjure up emotive concern about undue governmental interference undermining peoples' autonomy. But autonomy can be understood in various ways. We outline three main conceptions of autonomy, argue that these that can underpin three different conceptions of paternalism, and consider implications for responses to nanny-state accusations and the assessment of public health interventions. STUDY DESIGN AND METHODS: Detailed conceptual analysis. RESULTS: The conceptions of paternalism implicit in nanny-state accusations generally depend on libertarian conceptions of autonomy. These reflect unrealistic views of personal independence and do not discriminate sufficiently between trivial and important freedoms. Decisional conceptions of paternalism, like their underlying decisional conceptions of autonomy, have limited applicability in public health contexts. Relational conceptions of paternalism incorporate relational conceptions of autonomy, so recognize that personal autonomy depends on socially shaped skills, self-identities and self-evaluations as well as externally structured opportunities. They encourage attention to the various ways that social interactions and relationships, including disrespect, stigmatization and oppression, can undermine potential for autonomy. While nanny-state accusations target any interference with negative freedom, however trivial, relational conceptions direct concerns to those infringements of negative freedom, or absences of positive freedom, serious enough to undermine self-determination, self-governance and/or self-authorization. CONCLUSION: Relational conceptions of autonomy and paternalism offer public health policymakers and practitioners a means for rebutting nanny-state accusations, and can support more nuanced and more appropriately demanding appraisals of public health interventions.


Subject(s)
Health Promotion , Interpersonal Relations , Paternalism , Public Health , Dissent and Disputes , Health Promotion/ethics , Humans , Personal Autonomy , Program Evaluation , Public Health/ethics
4.
Health Educ Res ; 30(2): 193-205, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25502964

ABSTRACT

The use of evidence has become a foundational part of health promotion practice. Although there is a general consensus that adopting an evidence-based approach is necessary for practice, disagreement remains about what types of evidence practitioners should use to guide their work. An empirical understanding of how practitioners conceptualize and use evidence has been lacking in the literature. In this article, we explore (i) practitioners' purposes for using evidence, (ii) types of evidence they valued, and (iii) qualities that made evidence useful for practice. 58 semi-structured interviews and 250 h of participant and non-participant observation were conducted with 54 health promotion practitioners working across New South Wales, Australia. Interviews were recorded and transcribed, and field notes were written during the observations; these were analysed using Grounded Theory methods. Practitioners used evidence for practical and strategic purposes, and valued four different types of evidence according to their relevance and usefulness for these purposes. Practitioners' ideal evidence was generated within their practice settings, and met both substantive and procedural evaluation criteria. We argue that due to the complex nature of their work, practitioners rely on a diverse range of evidence and require organizational structures that will support them in doing so.


Subject(s)
Evidence-Based Practice/organization & administration , Health Promotion/organization & administration , Communication , Data Accuracy , Evidence-Based Practice/standards , Grounded Theory , Humans , New South Wales , Research Design
5.
Health Promot J Austr ; 24(2): 143-50, 2013 Aug.
Article in English | MEDLINE | ID: mdl-24168742

ABSTRACT

ISSUE ADDRESSED: Australians' use of cannabis has been increasing. Over a third of Australians (35.4%) have used cannabis at some time in their lives and 10.3% are recent users. Almost two-thirds of cannabis users combine cannabis with tobacco. The aim of this study was to understand the process of mulling - smoking tobacco and cannabis together - using a grounded theory approach. METHODS: Twenty-one in-depth semistructured interviews were conducted with men aged 25-34 and living on the North Coast of New South Wales. Interviews explored participants' smoking practices, histories and cessation attempts. RESULTS: A model describing mulling behaviour and the dynamics of smoking cannabis and tobacco was developed. It provides an explanatory framework that demonstrates the flexibility in smoking practices, including substance substitution - participants changed the type of cannabis they smoked, the amount of tobacco they mixed with it and the devices they used to smoke according to the situations they were in and the effects sought. CONCLUSION: Understanding these dynamic smoking practices and the importance of situations and effects, as well as the specific role of tobacco in mulling, may allow health workers to design more relevant and appropriate interventions. SO WHAT? Combining tobacco with cannabis is the most common way of smoking cannabis in Australia. However, tobacco cessation programmes rarely address cannabis use. Further research to develop evidence-based approaches for mull use would improve cessation outcomes.


Subject(s)
Smoking/epidemiology , Smoking/psychology , Adult , Australia , Behavior , Emotions , Employment , Humans , Interviews as Topic , Male , Marijuana Abuse/epidemiology , Marijuana Smoking/epidemiology , Marijuana Smoking/psychology , Smoking Cessation/methods , Tobacco Use Disorder/epidemiology
6.
J Med Screen ; 18(4): 193-203, 2011.
Article in English | MEDLINE | ID: mdl-22106435

ABSTRACT

OBJECTIVES: (i) To document the current state of the English, Scottish, Welsh, Northern Irish and Australian bowel cancer screening programmes, according to seven key characteristics, and (ii) to explore the policy trade-offs resulting from inadequate funding. SETTING: United Kingdom and Australia. METHODS: A comparative case study design using document and key informant interview analysis. Data were collated for each national jurisdiction on seven key programme characteristics: screening frequency, population coverage, quality of test, programme model, quality of follow-up, quality of colonoscopy and quality of data collection. A list of optimal features for each of the seven characteristics was compiled, based on the FOBT screening literature and our detailed examination of each programme. RESULTS: Each country made different implementation choices or trade-offs intended to conserve costs and/or manage limited and expensive resources. The overall outcome of these trade-offs was probable lower programme effectiveness as a result of compromises such as reduced screening frequency, restricted target age range, the use of less accurate tests, the deliberate setting of low programme positivity rates or increased inconvenience to participants from re-testing. CONCLUSIONS: Insufficient funding has forced programme administrators to make trade-offs that may undermine the potential net population benefits achieved in randomized controlled trials. Such policy compromise contravenes the principle of evidence-based practice which is dependent on adequate funding being made available.


Subject(s)
Colorectal Neoplasms/prevention & control , Mass Screening/methods , Australia/epidemiology , Colonoscopy , Colorectal Neoplasms/diagnosis , Colorectal Neoplasms/epidemiology , Evidence-Based Practice , Humans , Mass Screening/economics , Mass Screening/standards , Mass Screening/statistics & numerical data , Occult Blood , Program Evaluation , United Kingdom/epidemiology
7.
Br J Pharmacol ; 156(5): 857-67, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19220293

ABSTRACT

BACKGROUND AND PURPOSE: Diadenosine polyphosphates are normally present in cells at low levels, but significant increases in concentrations can occur during cellular stress. The aim of this study was to investigate the effects of diadenosine pentaphosphate (Ap5A) and an oxidized analogue, oAp5A on the gating of sheep cardiac ryanodine receptors (RyR2). EXPERIMENTAL APPROACH: RyR2 channel function was monitored after incorporation into planar bilayers under voltage-clamp conditions. KEY RESULTS: With10 micromol.L(-1) cytosolic Ca2+, a significant 'hump' or plateau at the base of the dose-response relationship to Ap5A was revealed. Open probability (Po) was significantly increased to a plateau of approximately 0.2 in the concentration range 100 pmol x L(-1)-10 micromol x L(-1). High Po values were observed at >10 micromol x L(-1) Ap5A, and Po values close to 1 could be achieved. Nanomolar levels of ATP and adenosine also revealed a hump at the base of the dose-response relationships, although GTP did not activate at any concentration, indicating a common, high-affinity binding site on RyR2 for adenine-based compounds. The oxidized analogue, oAp5A, did not significantly activate RyR2 via the high-affinity binding site; however, it could fully open the channel with an EC(50) of 16 micromol.L(-1) (Ap5A EC(50) = 140 micromol x L(-1)). Perfusion experiments suggest that oAp5A and Ap5A dissociate slowly from their binding sites on RyR2. CONCLUSIONS AND IMPLICATIONS: The ability of Ap5A compounds to increase Po even in the presence of ATP and their slow dissociation from the channel may enable these compounds to act as physiological regulators of RyR2, particularly under conditions of cellular stress.


Subject(s)
Adenine Nucleotides/metabolism , Calcium Channel Agonists/pharmacology , Dinucleoside Phosphates/pharmacology , Myocardium/metabolism , Ryanodine Receptor Calcium Release Channel/metabolism , Animals , Binding Sites , Calcium Channel Agonists/chemistry , Calcium Channel Agonists/metabolism , Dinucleoside Phosphates/chemistry , Dinucleoside Phosphates/metabolism , In Vitro Techniques , Ion Channel Gating , Ligands , Lipid Bilayers , Oxidation-Reduction , Patch-Clamp Techniques , Periodic Acid/chemistry , Phospholipids , Sarcoplasmic Reticulum/metabolism , Sheep
8.
Tob Control ; 14(6): 368-76, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16319359

ABSTRACT

OBJECTIVE: To understand the use of internal tobacco industry documents in the peer reviewed health literature. DESIGN: Interpretive analysis of published research. SAMPLE: 173 papers indexed in Medline between 1995 and 2004 that cited tobacco industry documents. ANALYSIS: Information about year published, journal and author, and a set of codes relating to methods reporting, were managed in N*Vivo. This coding formed the basis of an interpretation of tobacco document research reporting. RESULTS: Two types of papers were identified. The first used tobacco documents as the primary data source (A-papers). The second was dedicated to another purpose but cited a small number of documents (B-papers). In B-papers documents were used either to provide a specific example or to support an expansive contention. A-papers contained information about purpose, sources, searching, analysis, and limitations that differed by author and journal and over time. A-papers had no clear methodological context, but used words from three major traditions--interpretive research, positivist research, and history--to describe analysis. INTERPRETATION: A descriptive mainstream form of tobacco document reporting is proposed, initially typical but decreasing, and a continuum of positioning of the researcher, from conduit to constructor. Reporting practices, particularly from experienced researchers, appeared to evolve towards researcher as constructor, with later papers showing more complex purposes, diverse sources, and detail of searching and analysis. Tobacco document research could learn from existing research traditions: a model for planning and evaluating tobacco document research is presented.


Subject(s)
Documentation/methods , Research/standards , Tobacco Industry , Authorship , Bibliometrics , Humans , Information Storage and Retrieval/methods , Periodicals as Topic/statistics & numerical data , Publishing/statistics & numerical data , Publishing/trends
9.
Tob Control ; 12 Suppl 3: iii1-3, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14645941

ABSTRACT

"Australia is one of the darkest markets in the world... it probably is the darkest, I mean ourselves and Canada fight every month for who's got the darkest conditions to do tobacco manufacturing and marketing. And one of the things we can offer the world is what we do best, which is how to work, maximize, proactively drive our market position in a market that's completely dark. Now that takes a different skillset... a different type of learning. We need to export that... we know we have a lot of expatriates who come down to Australia for learning. they can come here and learn these techniques and take them back to Europe or Latin America or to the United States or to Africa... But the other thing that is really good for us is that we are also a huge net exporter of Australian talent. about 30 or 40 people currently off-shore... We do things really differently here than most other BAT organizations." David Crowe, Marketing Director, British American Tobacco (BAT) Australia(1).


Subject(s)
Smoking Prevention , Tobacco Industry , Australia , Humans , Publishing , Smoking/legislation & jurisprudence
10.
Tob Control ; 12 Suppl 3: iii13-22, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14645944

ABSTRACT

OBJECTIVE: To review critically the history of Australian tobacco industry efforts to avoid, delay, and dilute pack warnings on cigarettes. DESIGN: Systematic keyword and opportunistic website searches of tobacco industry internal documents made available through the Master Settlement Agreement. RESULTS: Four industry strategies and six recurrent arguments used by the industry are described, which were used to thwart the passage of three generations of health warnings (implemented in 1973, 1987, and 1995). These strategies are shown to have been associated with major delays in the implementation of the warnings and in keeping them inconspicuous, unattributed to the industry and non-specific, and particularly in delaying the use of warnings about addiction. The industry today continues to oppose warnings, which might "repel" smokers from tobacco use. CONCLUSIONS: Efforts by governments to introduce potent health warnings will be resisted by the tobacco industry. Tobacco control advocates should anticipate and counter the strategies and arguments used by the industry, which are described in this paper if they wish to maximise the use of the pack as a vehicle for raising awareness about the harms of smoking.


Subject(s)
Product Labeling , Smoking Prevention , Tobacco Industry , Australia , Health Promotion , Humans
11.
Tob Control ; 12 Suppl 3: iii23-30, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14645945

ABSTRACT

OBJECTIVE: To contrast the Australian tobacco industry's awareness of the diseases caused by smoking with their aggressive public denial on the relation between smoking and disease in the 1980s. DESIGN: Analysis of 325 industry documents from the world wide web. RESULTS: In the 1980s Australian cigarette manufacturers were informed constantly by the international industry of the medical consensus that smoking caused disease. In addition Philip Morris (Australia) Limited received reports of Philip Morris' international biological research programme and visited its Richmond research facility; and WD&HO Wills part funded, co-managed, and contributed research to the British American Tobacco groups' biological research programme. Despite this knowledge, the Australian manufacturers had a policy of arguing to their employees, decision makers, and the general public that questions of smoking and disease were unresolved. The industry catalogued the literature, developed arguments against the main claims made by health groups, and attacked public health advocates who made statements linking smoking to death and disease. Industry studies suggested that a 20-30% minority of the Australian public agreed with the industry on smoking and disease, diminishing across the decade. CONCLUSION: Australian manufacturers were clearly negligent in the 1980s, deliberately working to undermine Australians' understandings of the diseases caused by smoking despite their own private knowledge. Continuing scepticism about smoking and disease, corresponding with the industry's deceptions, exists in Australian smokers today, suggesting that their actions may have slowed the rate of decline in smoking prevalence. These revelations provide important evidence for Australian litigation and advocacy.


Subject(s)
Denial, Psychological , Smoking/adverse effects , Tobacco Industry , Australia , Biomedical Research , Communication , Consumer Product Safety , Humans , Propaganda , Smoking/psychology
12.
Tob Control ; 12 Suppl 3: iii38-44, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14645947

ABSTRACT

OBJECTIVES: (1) To review the history of the tobacco industry supported Australian Tobacco Research Foundation (ATRF)(1970-1994) for evidence of the industry's use of the Foundation to further its objectives that "more research was needed" on smoking and health and to promulgate the view that nicotine was not addictive. (2) To review efforts by public health advocates to discredit the ATRF as a public relations tool used by the Australian industry. METHODS: Systematic search of previously internal industry documents released through the US Master Settlement Agreement. RESULTS: The ATRF was headed by prestigious Australian medical scientists, with at least one considered by the industry to be "industry positive". An international ATRF symposium on nicotine was vetted by the industry and heavily attended by industry approved scientists. Following sustained criticism from the health and medical community about the industry's creation of the ATRF to further its objectives, the ATRF's scientific committee was provoked to publicly declare in 1988 that smoking was a causative agent in disease. This criticism led to growing ATRF boycotts by scientists and substandard applications, causing the industry to see the ATRF as being poor value-for-money and eventually abandoning it. CONCLUSIONS: The raison d'etre for the ATRF's establishment was to allow the Australian industry to point to its continuing commitment to independent medical research, with the implied corollary that tobacco control measures were premature in the face of insufficient evidence about tobacco's harms. Sustained criticism of tobacco industry funded research schemes can undermine their credibility among the scientific community.


Subject(s)
Foundations , Smoking , Tobacco Industry , Australia , Biomedical Research , Health Education , Humans , Research Support as Topic , Tobacco Use Disorder
13.
Tob Control ; 12 Suppl 3: iii54-60, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14645949

ABSTRACT

OBJECTIVE: To describe the history of the Tobacco Institute of Australia (TIA), particularly regarding connections between local and international cigarette manufacturers and tobacco organisations. DESIGN: Analysis of 4541 industry documents from the world wide web. RESULTS: From 1978 to 1983 the TIA built strong international networks via ICOSI/INFOTAB and the US Tobacco Institute, and defended existing industry freedoms. 1983 to 1989 was the TIA's aggressive heyday, led primarily by John Dollisson. From 1989 to 1994, following the decision in Australian Federation of Consumer Organisations vs TIA, local and international industry lawyers assumed control. Between 1994 and 1997 a brief revival led into decline and then dissolution, as previously common ground became commercially competitive issues for the manufacturers. The TIA facilitated interconnectedness: between local manufacturers; via individuals who played multiple roles; to international tobacco organisations; through the industry's local and international counsel; and by acting as a conduit for information. CONCLUSION: The local tobacco industry was comprehensively informed on issues including smoking and health, and connected to the international industry, via the TIA. The manufacturers were closely involved in the TIA's activities, and cooperated through the TIA in a manner detrimental to Australian consumers. The TIA's conduct was the responsibility of local and international manufacturers and their counsel.


Subject(s)
Academies and Institutes , Interprofessional Relations , Smoking/trends , Tobacco Industry/trends , Australia , Humans , Smoking/adverse effects
14.
Tob Control ; 12 Suppl 3: iii71-8, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14645951

ABSTRACT

OBJECTIVE: To document the Australian tobacco industry's activities regarding youth smoking to support tobacco control. METHOD: 492 industry documents from primary and secondary websites were abstracted and analysed. RESULTS: Australian legislation and rhetoric on youth and tobacco has changed dramatically over the last 50 years, from an unproblematic association of teenagers and smoking in the 1960s, through the industry's aggressive attacks and denials in the 1980s, to the 1990s, when industry became newly compliant with "societal expectations" and youth became a dominant bargaining issue in the industry's public relations strategy. The industry's current policy is to simultaneously blame others for underage smoking, frame the industry as socially responsible via voluntary marketing codes, youth access programmes, and school education, and market actively to young adults. CONCLUSIONS: The arbitrary distinction between 17 and 18 year olds is, particularly in Australia's dark market, a liability for tobacco control and an opportunity for the industry, which is attempting to claim the high moral ground traditionally occupied by tobacco control on the youth issue. The current review of Australia's Tobacco Advertising Prohibition Act of 1992 should prohibit all forms of industry communication targeting young people, including retail access and schools programmes and below-the-line marketing. Tobacco control advocacy should highlight the industry's attempts to use the youth issue in its own favour while laying the blame elsewhere.


Subject(s)
Public Relations , Smoking , Tobacco Industry , Adolescent , Australia , Codes of Ethics , Humans , International Cooperation , Marketing/ethics , Marketing/legislation & jurisprudence , Organizational Policy , Smoking/legislation & jurisprudence , Smoking/psychology , Tobacco Industry/ethics , Tobacco Industry/legislation & jurisprudence
15.
Tob Control ; 12 Suppl 3: iii61-70, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14645950

ABSTRACT

OBJECTIVE: To document the development of the low tar harm reduction programme in Australia, including tobacco industry responses. DATA SOURCES: Tobacco industry documents, retail tobacco journals, newspapers, medical journals, and Anti-Cancer Council of Victoria (ACCV) newsletters and archival records. STUDY SELECTION: Documents on the strategies and knowledge bases of the ACCV, other Australian health authorities, and the tobacco industry. RESULTS: The ACCV built a durable system for measuring and publicising the tar and nicotine yields of Australian cigarettes and influencing their development. The tobacco industry initially sought to block the development of this system but later appeared to cooperate with it, as is evidenced by the current market dominance of low tar brands. However, behind the scenes, the industry used its substantial knowledge advantage regarding compensatory smoking and its ability to re-engineer cigarettes to gain effective control of the system and subvert the ACCV's objectives. CONCLUSIONS: Replacement of the low tar programme with new means of minimising the harms from cigarette smoking should be a policy priority for the Australian government. This will require regulation, rather than further voluntary agreements, and stringent monitoring of successor programmes will be necessary.


Subject(s)
Harm Reduction , Smoking Prevention , Tars , Australia , Health Promotion/methods , Humans , Marketing , Program Evaluation , Nicotiana/chemistry , Tobacco Industry
16.
Tob Control ; 12 Suppl 3: iii79-86, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14645952

ABSTRACT

OBJECTIVE: To examine, for dominant Australian cigarette brands, brand identity (overriding brand vision), brand positioning (brand identity elements communicated to the consumer), brand image (consumers' brand perceptions) and brand equity (financial value). DESIGN: Tobacco industry documents, articles from retail trade publications since 1990, and current brand advertising from retail trade publications were searched for information about Australian brands. RESULTS: Cigarette manufacturers benefit from their competitors' brand equity as well as their own. The industry sees Australian smokers as far less brand loyal and strongly oriented to "low tar". A few predominantly local brands dominate the market, with variation by state. Successful Australian brands exist in one of three categories: premium, mainstream, and supervalue. Their brand identity essence is as follows. Premium: quality. Mainstream: a good humoured "fair go" for ordinary Australians. Supervalue: value for money. All supervalue brand identities also include freedom, escape, mildness, an aspirational attitude, blue tones, and waterside scenes. Brand image and brand identity is frequently congruent, even when marketing is restricted, and brand image is generally more positive for a smoker's own brand. CONCLUSIONS: Tobacco control activities have undermined cigarette brand equity. Further research is needed regarding brand loyalty, low tar, and brand categories. Smokers may respond more positively to tobacco control messages consistent with the identities of their chosen brand, and brand-as-organisation elements may assist. Further marketing restrictions should consider all elements of brand identity, and aim to undermine brand categories.


Subject(s)
Marketing , Smoking/psychology , Tobacco Industry , Advertising , Australia , Humans , Product Labeling , Product Packaging , Symbolism
17.
Tob Control ; 12 Suppl 3: iii87-94, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14645953

ABSTRACT

OBJECTIVE: To investigate non-point-of-sale cigarette marketing in Australia, one of the "darkest" markets in the world. DESIGN: Analysis of 172 tobacco industry documents. RESULTS: The tobacco industry has continued to market their products despite severe restrictions on legal marketing activity. They made careful plans to circumvent regulation well in advance. In preparation for bans, they chose and strengthened existing brands to enable their continued success in a dark market and prepared the consumer for bans by increasing their spending on below the line activities. Bans reduced the industry's effectiveness and efficiency. After bans new brand launches stopped: instead key existing brands were strengthened via alterations to the product, line extensions, and stretching loopholes in the legislation as far as possible. In line with the general trend towards integrated marketing, a range of activities have been used in combination, including guerrilla marketing, advertising in imported international magazines, altering the pack, sponsorships, brand stretching, event promotions, lifestyle premiums, and the development of corporate websites. CONCLUSIONS: The tobacco industry acknowledges that marketing restrictions have an impact, validating their continued use in tobacco control. The industry is extremely creative in circumventing these marketing restrictions, requiring tobacco marketing regulations to be informed by marketing expertise, regularly updated, and to adopt the broadest possible scope. Tobacco control advocates, particularly those communicating with young people, could learn from the creativity of the tobacco industry.


Subject(s)
Marketing , Smoking/economics , Tobacco Industry/economics , Australia , Humans
18.
Tob Control ; 12 Suppl 3: iii95-101, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14645954

ABSTRACT

OBJECTIVE: To investigate the role of the retail environment in cigarette marketing in Australia, one of the "darkest" markets in the world. DESIGN: Analysis of 172 tobacco industry documents; and articles and advertisements found by hand searching Australia's three leading retail trade journals. RESULTS: As Australian cigarette marketing was increasingly restricted, the retail environment became the primary communication vehicle for building cigarette brands. When retail marketing was restricted, the industry conceded only incrementally and under duress, and at times continues to break the law. The tobacco industry targets retailers via trade promotional expenditure, financial and practical assistance with point of sale marketing, alliance building, brand advertising, and distribution. Cigarette brand advertising in retail magazines are designed to build brand identities. Philip Morris and British American Tobacco are now competing to control distribution of all products to retailers, placing themselves at the heart of retail business. CONCLUSIONS: Cigarette companies prize retail marketing in Australia's dark market. Stringent point of sale marketing restrictions should be included in any comprehensive tobacco control measures. Relationships between retailers and the industry will be more difficult to regulate. Retail press advertising and trade promotional expenditure could be banned. In-store marketing assistance, retail-tobacco industry alliance building, and new electronic retail distribution systems may be less amenable to regulation. Alliances between the health and retail sectors and financial support for a move away from retail dependence on tobacco may be necessary to effect cultural change.


Subject(s)
Marketing , Smoking/economics , Tobacco Industry/economics , Advertising/economics , Australia , Capital Expenditures , Humans , Interprofessional Relations
19.
Ultrasound Obstet Gynecol ; 17(4): 354-6, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11339197

ABSTRACT

Bardet-Biedl syndrome (BBS) is an autosomal recessive disorder characterized by mental retardation, obesity, retinal degeneration, polydactyly and syndactyly, diabetes mellitus, hypogenitalism, renal dysplasia and short stature. Definitive molecular diagnosis for BBS is not currently available and counseling of affected families is based on the 25% recurrence risk consistent with autosomal recessive inheritance. Our case presents the first successful use of second trimester targeted sonographic anatomy scanning to prospectively identify a fetus affected with BBS, and indicates that ultrasound can be of critical importance in providing precise as well as timely prenatal diagnosis for families at risk for this serious disorder.


Subject(s)
Bardet-Biedl Syndrome/diagnostic imaging , Ultrasonography, Prenatal , Adult , Diagnosis, Differential , Female , Humans , Pregnancy , Pregnancy Trimester, Second
20.
Br J Pharmacol ; 129(3): 457-64, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10711343

ABSTRACT

1. Transintestinal absorption of gamma-aminobutyric acid (GABA) via a pH-dependent mechanism is demonstrated in the model human intestinal epithelial cell line Caco-2. 2. Experiments with BCECF [2',7',-bis(2-carboxyethyl)-5(6)- carboxyfluorescein]-loaded Caco-2 cells demonstrate that GABA transport across the apical membrane is coupled to proton flow into the cell. 3. Short-circuit current (ISC) measurements using Caco-2 cell monolayers under voltage-clamped conditions demonstrate that pH-dependent GABA transport is a rheogenic process even in the absence of extracellular Na+, consistent with H+/GABA symport. 4. A range of GABA analogues were tested for their abilities to: (a) inhibit pH-dependent [3H]GABA uptake across the apical membrane; (b) stimulate H+ flow across the apical surface of BCECF-loaded Caco-2 cell monolayers; (c) increase inward ISC across voltage-clamped Caco-2 cell monolayers. 5. Nipecotic acid, isonipecotic acid, D,L-beta-aminobutyric acid, and 3-amino-1-propanesulphonic acid each caused a marked acidification of intracellular pH and an increase in ISC when superfused at the apical surface of Caco-2 cell monolayers. In contrast L-alpha-amino-n-butyric acid failed to induce proton flow or ISC. The ability of these compounds to induce proton or current flow across the apical surface of this intestinal epithelium was closely related to the relative inhibitory effects on [3H]GABA uptake. 6. These observations demonstrate H+/GABA symport and suggest that this transport mechanism may be accessible as a route for oral absorption of therapeutically-useful GABA analogues.


Subject(s)
Epithelial Cells/metabolism , Intestinal Mucosa/metabolism , gamma-Aminobutyric Acid/metabolism , Biological Transport , Caco-2 Cells , Carrier Proteins/metabolism , Fluorescent Dyes , GABA Agonists/pharmacology , GABA Antagonists/pharmacology , Humans , Hydrogen/metabolism , Hydrogen-Ion Concentration , Patch-Clamp Techniques , Receptors, GABA/drug effects , gamma-Aminobutyric Acid/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL